EUVIMEDEUVIMED entdecken
Crossref

Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials

Ruth N Moro iD, John L Johnson iD, Neil Martinson, Grace Muzanyi, Chi-Chiu Leung, Kwok-Chiu Chang, Ziyaad Waja iD, Stefan V Goldberg iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Ruth N Moro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Neutrophils, Neutropenia, Rifampin, Tuberculosis. Die Arbeit nennt 41 Literaturangaben. Gefördert von: CDC HHS, Sanofi US, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Differences in absolute neutrophil count (ANC) between African and non-African populations have been reported. Neutropenia has also been reported during rifamycin use. ANC values in current tables that assign severity grades to clinical or laboratory events (National Cancer Institute Common Terminology Criteria for Adverse Events [CTCAE] and the National Institute of Allergy and Infectious Diseases Division of AIDS [DAIDS]) might not consistently be applicable among different populations.

Methods

During 2 international tuberculosis treatment trials, 337 participants received 10 mg/kg of rifampin, and 3 groups of 361, 81, and 81 participants received 10, 15, and 20 mg/kg of rifapentine, respectively, for 2 months of daily treatment. ANC was measured at baseline and after 2, 4, 6, 8, and 12 weeks of treatment. CTCAE versions 2.0–4.0 and DAIDS version 2.0 define neutropenia grade 3 as ANC 500–999 cells/μL and ANC 400–599 cells/μL, respectively. We analyzed factors associated with neutropenia.

Results

Baseline median ANC was lower in Black African participants than in Black non-African participants (P = .004). CTCAE-defined grade 3 or higher neutropenia occurred in 32 (28 in Africa) participants. Proportions did not differ between rifapentine doses. Only 4 events would have been reported by DAIDS criteria. All neutropenia events resolved spontaneously without interrupting treatment. Enrollment in an African country was an independent factor associated with the development of neutropenia.

Conclusions

Differences in baseline median ANC can result in misclassification of adverse events or inappropriate clinical management. Development and use of population-specific normal values of ANC could improve guidance for research and clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsNeutropeniaRifampinTuberculosisAntitubercular AgentsHumansMaleFemaleLeukocyte CountAdultMiddle AgedBlack PeopleAfricaYoung Adult

Stichwörter der Autor:innen

Africaabsolute neutrophil countethnic leukopenianeutropeniatuberculosis

Substanzen

RifampinrifapentineAntitubercular Agents

Autor:innen und Institutionen

  • Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda.
  • Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Johns Hopkins Center for Tuberculosis Research, School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Ruth N Moro, John L Johnson, Ziyaad Waja, Stefan V Goldberg

Förderung

  • CDC HHS
  • Sanofi US
  • Centers for Disease Control and Prevention

Zitieren

APA

Moro, R. N., Johnson, J. L., Martinson, N., Muzanyi, G., Leung, C. C., Chang, K. C., Waja, Z., & Goldberg, S. V. (2025). Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf291

Vancouver

Moro RN, Johnson JL, Martinson N, Muzanyi G, Leung CC, Chang KC, et al. Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf291

BibTeX
@article{Moro2025,
  author = {Moro, Ruth N and Johnson, John L and Martinson, Neil and Muzanyi, Grace and Leung, Chi-Chiu and Chang, Kwok-Chiu and Waja, Ziyaad and Goldberg, Stefan V},
  title = {Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf291}
}
Kostenlos starten →